Latest news with #RobertBrooks
Yahoo
04-08-2025
- Yahoo
Former New York prison guard sentenced to 15 years for beating death of inmate
UTICA, N.Y. (AP) — A former corrections officer was sentenced to 15 years in prison Monday for his role in the death of a Black inmate whose beating by a group of guards at an upstate New York prison was captured on bodycam videos. Christopher Walrath was one of six guards charged with murder in the death of Robert Brooks, who was pummeled at the Marcy Correctional Facility on Dec. 9. Walrath pleaded guilty to first-degree manslaughter in May under the first plea deal among the guards charged with murder. 'In that video, I see you and your fellow officers treating him as if his life holds no value at all, as if you're entitled to brutalize him for sport,' Robert Brooks Jr., the victim's son, told the court. The son said in his victim impact statement that, 'I am not OK and I never will be.' Brooks had been serving a 12-year sentence for first-degree assault since 2017 and was transferred to Marcy from a nearby lockup on the night he was beaten. The videos show Brooks being struck in the chest with a shoe, lifted by his neck and then dropped. Under questioning in May from Onondaga County District Attorney William Fitzpatrick, Walrath admitted that he and other guards assaulted Brooks, that he put Brooks in a chokehold, and that he struck the inmate's body and groin. In addition to the six guards charged in February with murder, three more prison workers were indicted for manslaughter and another for evidence tampering. Prosecutors have said three other prison workers have reached agreements. A guard pleaded guilty in May to attempted tampering with physical evidence and was sentenced to a one-year conditional discharge. Trials were scheduled to begin in October for guards who have rejected plea deals. Fitzpatrick also is prosecuting guards in the fatal beating of Messiah Nantwi on March 1 at another Marcy lockup, the Mid-State Correctional Facility. Ten guards were indicted in April, including two who are charged with murder. Both prisons are about 180 miles (290 kilometers) northwest of New York City.
Toronto Star
04-08-2025
- Toronto Star
Former New York prison guard sentenced to 15 years for beating death of inmate
UTICA, N.Y. (AP) — A former corrections officer was sentenced to 15 years in prison Monday for his role in the death of a Black inmate whose beating by a group of guards at an upstate New York prison was captured on bodycam videos. Christopher Walrath was one of six guards charged with murder in the death of Robert Brooks, who was pummeled at the Marcy Correctional Facility on Dec. 9. Walrath pleaded guilty to first-degree manslaughter in May under the first plea deal among the guards charged with murder.
The Independent
04-08-2025
- The Independent
Former New York prison guard sentenced to 15 years for beating death of inmate
A former corrections officer was sentenced to 15 years in prison Monday for his role in the death of a Black inmate whose beating by a group of guards at an upstate New York prison was captured on bodycam videos. Christopher Walrath was one of six guards charged with murder in the death of Robert Brooks, who was pummeled at the Marcy Correctional Facility on Dec. 9. Walrath pleaded guilty to first-degree manslaughter in May under the first plea deal among the guards charged with murder. 'In that video, I see you and your fellow officers treating him as if his life holds no value at all, as if you're entitled to brutalize him for sport,' Robert Brooks Jr., the victim's son, told the court. The son said in his victim impact statement that, 'I am not OK and I never will be.' Brooks had been serving a 12-year sentence for first-degree assault since 2017 and was transferred to Marcy from a nearby lockup on the night he was beaten. The videos show Brooks being struck in the chest with a shoe, lifted by his neck and then dropped. Under questioning in May from Onondaga County District Attorney William Fitzpatrick, Walrath admitted that he and other guards assaulted Brooks, that he put Brooks in a chokehold, and that he struck the inmate's body and groin. In addition to the six guards charged in February with murder, three more prison workers were indicted for manslaughter and another for evidence tampering. Prosecutors have said three other prison workers have reached agreements. A guard pleaded guilty in May to attempted tampering with physical evidence and was sentenced to a one-year conditional discharge. Trials were scheduled to begin in October for guards who have rejected plea deals. Fitzpatrick also is prosecuting guards in the fatal beating of Messiah Nantwi on March 1 at another Marcy lockup, the Mid-State Correctional Facility. Ten guards were indicted in April, including two who are charged with murder.
Associated Press
04-08-2025
- Associated Press
Former New York prison guard sentenced to 15 years for beating death of inmate
UTICA, N.Y. (AP) — A former corrections officer was sentenced to 15 years in prison Monday for his role in the death of a Black inmate whose beating by a group of guards at an upstate New York prison was captured on bodycam videos. Christopher Walrath was one of six guards charged with murder in the death of Robert Brooks, who was pummeled at the Marcy Correctional Facility on Dec. 9. Walrath pleaded guilty to first-degree manslaughter in May under the first plea deal among the guards charged with murder. 'In that video, I see you and your fellow officers treating him as if his life holds no value at all, as if you're entitled to brutalize him for sport,' Robert Brooks Jr., the victim's son, told the court. The son said in his victim impact statement that, 'I am not OK and I never will be.' Brooks had been serving a 12-year sentence for first-degree assault since 2017 and was transferred to Marcy from a nearby lockup on the night he was beaten. The videos show Brooks being struck in the chest with a shoe, lifted by his neck and then dropped. Under questioning in May from Onondaga County District Attorney William Fitzpatrick, Walrath admitted that he and other guards assaulted Brooks, that he put Brooks in a chokehold, and that he struck the inmate's body and groin. In addition to the six guards charged in February with murder, three more prison workers were indicted for manslaughter and another for evidence tampering. Prosecutors have said three other prison workers have reached agreements. A guard pleaded guilty in May to attempted tampering with physical evidence and was sentenced to a one-year conditional discharge. Trials were scheduled to begin in October for guards who have rejected plea deals. Fitzpatrick also is prosecuting guards in the fatal beating of Messiah Nantwi on March 1 at another Marcy lockup, the Mid-State Correctional Facility. Ten guards were indicted in April, including two who are charged with murder. Both prisons are about 180 miles (290 kilometers) northwest of New York City.
Business Wire
26-06-2025
- Business
- Business Wire
Iambic Taps Lambda for Increased AI Compute as it Develops the Next Generation of Enchant, a Breakthrough AI Molecular Property Prediction Model for Drug Discovery
SAN JOSE, Calif.--(BUSINESS WIRE)--Lambda, the GPU cloud company founded by AI engineers, today announced that Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, has selected Lambda to provide an NVIDIA HGX B200 cluster to support the training of Enchant, its industry-leading model for molecular property prediction. Iambic's Enchant is a breakthrough multi-modal transformer model for predicting clinical and preclinical endpoints related to the drug discovery and development process. Enchant enables researchers to determine the viability of new drug molecules and make high-confidence predictions where data is most sparse, helping address the critical real-world challenge of understanding how novel drug candidates may affect a patient while still in the earliest stages of discovery. Iambic's recently announced Enchant v2 provides accurate predictions for dozens of biological, physiochemical, pharmacokinetic, metabolic, safety, and other properties essential for clinical success. 'With the release of Enchant v2, we demonstrated both the model's accuracy and scalability and we believe we can rapidly build on these gains through model scale alone,' said Matt Welborn, PhD, Iambic's VP of Machine Learning. 'We are expanding our successful relationship with Lambda to an NVIDIA HGX B200 cluster, which will accelerate this opportunity and the breadth of pre-clinical and clinical endpoints Enchant can predict, increasing the likelihood of a molecules' success in human studies and the efficiency of drug development.' Enchant's high-confidence predictions enable multi-parameter optimization for the design of potentially more effective medicines, program prioritization, and the design of clinical trials for the potentially rapid translation of novel medicines. Iambic researchers also demonstrated that in some cases Enchant can be a better predictor of in vivo drug clearance than in vitro experiments – a key advancement as regulators look for drug developers to broaden their use of in silico testing. Today, Enchant is the leading model in the field based on performance benchmarks across diverse molecular property prediction tasks. 'We're thrilled to deepen our partnership with Iambic, a leader in AI-driven drug discovery,' said Robert Brooks IV, Founding Team and VP, Revenue. 'By leveraging Lambda's 1-Click Clusters for rapid testing and validation, Iambic was able to seamlessly scale to an NVIDIA HGX B200 cluster to accelerate breakthroughs in life sciences.' To learn more about Lambda's cloud offerings for AI training and inference, click here. About Iambic's AI-Driven Discovery Platform The Iambic AI-driven platform was created to address the most challenging design problems in drug discovery, leveraging technology innovations such as Enchant (multimodal transformer model that predicts clinical and preclinical endpoints) and NeuralPLexer (best-in-class predictor of protein and protein-ligand structures). The integration of physics principles into the platform's AI architectures improves data efficiency and allows molecular models to venture widely across the space of possible chemical structures. The platform enables identification of novel chemical modalities for engaging difficult-to-address biological targets, discovery of defined product profiles that optimize therapeutic window, and multiparameter optimization for highly differentiated development candidates. Through close integration of AI-generated molecular designs with automated chemical synthesis and experimental execution, Iambic completes design-make-test cycles on a weekly cadence. About Iambic Therapeutics Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedented speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets, both internally and in partnership, to address urgent unmet patient need. Learn more about the Iambic team, platform, pipeline, and partnerships at About Lambda Lambda was founded in 2012 by AI engineers with published research at the top machine learning conferences in the world. Our goal is to become the #1 AI compute platform serving developers across the entire AI development lifecycle. We enable AI engineers to easily, securely and affordably build, test and deploy AI products at scale. Our product portfolio spans from on-prem GPU hardware to hosted GPUs in the cloud. Lambda's mission is to create a world where access to computation is as effortless and ubiquitous as electricity.
